QuIP’s Scientific Advisory Board
The scientific advisory board is an advisory body for QuIP GmbH. The advisory board discusses all relevant issues as well as developments and drafts recommendations for the shareholders. Decisions of the scientific advisory board are of a consultative nature for the shareholders and the management. The members of the advisory board have proven expertise in the field of quality assurance, especially in pathology, are recognized experts in several tumor entities and have many years of experience in the conception and implementation of proficiency testing.
The recommendations of the advisory board are put into effect by approval of the shareholders. The advisory board consists of a maximum of eight voting members; non-voting members are the chairperson of the DGP, the president of the German Association of Pathologists, the chairperson of the Pathology Sector Committee of the German Accreditation Body (DAkkS) and the spokesperson of the Oncology Pathology Working Group (AOP) within the German Cancer Society (DKG).
The scientific advisory board determines, among other things, the lead panel and panel institutes and usually convenes twice a year.